NAFLD-the next global epidemic - PubMed (original) (raw)

Editorial

NAFLD-the next global epidemic

Katrina Ray. Nat Rev Gastroenterol Hepatol. 2013 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
  Rahimi RS, Landaverde C. Rahimi RS, et al. Nutr Clin Pract. 2013 Feb;28(1):40-51. doi: 10.1177/0884533612470464. Epub 2013 Jan 3. Nutr Clin Pract. 2013. PMID: 23286927 Review.
• [Non-alcoholic fatty liver disease in children: a new complication of obesity].
  Bocca G, Stolk RP, Scheenstra R, Sauer PJ. Bocca G, et al. Ned Tijdschr Geneeskd. 2008 Nov 8;152(45):2443-7. Ned Tijdschr Geneeskd. 2008. PMID: 19051794 Review. Dutch.
• Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
  Papandreou D, Karabouta Z, Pantoleon A, Rousso I. Papandreou D, et al. Appetite. 2012 Dec;59(3):939-44. doi: 10.1016/j.appet.2012.09.006. Epub 2012 Sep 18. Appetite. 2012. PMID: 23000278
• The epidemiology of nonalcoholic fatty liver disease: a global perspective.
  Lazo M, Clark JM. Lazo M, et al. Semin Liver Dis. 2008 Nov;28(4):339-50. doi: 10.1055/s-0028-1091978. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956290 Review.
• Advances in pediatric nonalcoholic fatty liver disease.
  Mencin AA, Lavine JE. Mencin AA, et al. Pediatr Clin North Am. 2011 Dec;58(6):1375-92, x. doi: 10.1016/j.pcl.2011.09.005. Epub 2011 Oct 14. Pediatr Clin North Am. 2011. PMID: 22093857 Review.

Cited by

• DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma.
  Huang JC, Emran AA, Endaya JM, McCaughan GW, Gorrell MD, Zhang HE. Huang JC, et al. Cancers (Basel). 2021 Apr 1;13(7):1637. doi: 10.3390/cancers13071637. Cancers (Basel). 2021. PMID: 33915844 Free PMC article.
• The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults.
  Kathak RR, Sumon AH, Molla NH, Hasan M, Miah R, Tuba HR, Habib A, Ali N. Kathak RR, et al. Sci Rep. 2022 Feb 2;12(1):1711. doi: 10.1038/s41598-022-05766-y. Sci Rep. 2022. PMID: 35110625 Free PMC article.
• Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells.
  Albracht-Schulte K, Gonzalez S, Jackson A, Wilson S, Ramalingam L, Kalupahana NS, Moustaid-Moussa N. Albracht-Schulte K, et al. Nutrients. 2019 Mar 12;11(3):599. doi: 10.3390/nu11030599. Nutrients. 2019. PMID: 30871035 Free PMC article.
• Environmental risk factors for liver cancer and nonalcoholic fatty liver disease.
  VoPham T. VoPham T. Curr Epidemiol Rep. 2019 Mar;6(1):50-66. doi: 10.1007/s40471-019-0183-2. Epub 2019 Feb 6. Curr Epidemiol Rep. 2019. PMID: 31080703 Free PMC article.
• Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
  Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ. Jensen T, et al. J Hepatol. 2018 May;68(5):1063-1075. doi: 10.1016/j.jhep.2018.01.019. Epub 2018 Feb 2. J Hepatol. 2018. PMID: 29408694 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information